サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は避妊具市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは避妊具の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の避妊具市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは避妊具のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に避妊具市場を分類しています。本研究に含まれる主な企業は：Merck、Pfizer、Teva Pharmaceutical、Bayer、Allergan、Janssen、Mankind Pharma、Piramal Enterprises、Reckitt Benckiser、Church & Dwight

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Oral
    Injectable
    Others

用途別の市場セグメント：
    Hospitals
    Clinics
    Others

本レポートの詳細内容
世界の避妊具市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、避妊具タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の避妊具収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の避妊具市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、避妊具市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

避妊具のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：避妊具のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：避妊具の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章避妊具企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：避妊具の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：避妊具の主要企業の概要を提供し、製品の説明と仕様、避妊具の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Contraceptive Drugs are medications that prevent pregnancy. They are one method of birth control
Market Analysis and Insights: Global Contraceptive Drugs Market
The global Contraceptive Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Birth controls are been used since ancient times but the safe and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg.
Report Covers:
This report presents an overview of global market for Contraceptive Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Contraceptive Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Contraceptive Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contraceptive Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Contraceptive Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Contraceptive Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Pfizer, Teva Pharmaceutical, Bayer, Allergan, Janssen, Mankind Pharma, Piramal Enterprises and Reckitt Benckiser, etc.

Market Segmentation
By Company
    Merck
    Pfizer
    Teva Pharmaceutical
    Bayer
    Allergan
    Janssen
    Mankind Pharma
    Piramal Enterprises
    Reckitt Benckiser
    Church & Dwight

Segment by Type
    Oral
    Injectable
    Others

Segment by Application
    Hospitals
    Clinics
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Contraceptive Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptive Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptive Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Contraceptive Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Injectable
    Table 4. Key Players of Others
    Table 5. Global Contraceptive Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Contraceptive Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Contraceptive Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Contraceptive Drugs Market Share by Region (2019-2024)
    Table 9. Global Contraceptive Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Contraceptive Drugs Market Share by Region (2025-2030)
    Table 11. Contraceptive Drugs Market Trends
    Table 12. Contraceptive Drugs Market Drivers
    Table 13. Contraceptive Drugs Market Challenges
    Table 14. Contraceptive Drugs Market Restraints
    Table 15. Global Contraceptive Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Contraceptive Drugs Revenue Share by Players (2019-2024)
    Table 17. Global Top Contraceptive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Drugs as of 2023)
    Table 18. Global Contraceptive Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Contraceptive Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Contraceptive Drugs, Headquarters and Area Served
    Table 21. Global Key Players of Contraceptive Drugs, Product and Application
    Table 22. Global Key Players of Contraceptive Drugs, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Contraceptive Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Contraceptive Drugs Revenue Market Share by Type (2019-2024)
    Table 26. Global Contraceptive Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Contraceptive Drugs Revenue Market Share by Type (2025-2030)
    Table 28. Global Contraceptive Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Contraceptive Drugs Revenue Share by Application (2019-2024)
    Table 30. Global Contraceptive Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Contraceptive Drugs Revenue Share by Application (2025-2030)
    Table 32. North America Contraceptive Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Contraceptive Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Contraceptive Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Contraceptive Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Contraceptive Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Contraceptive Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Contraceptive Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Contraceptive Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Contraceptive Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Contraceptive Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Contraceptive Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Contraceptive Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Contraceptive Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Contraceptive Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Contraceptive Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Contraceptive Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Contraceptive Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Contraceptive Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Contraceptive Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Contraceptive Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Contraceptive Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Contraceptive Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Contraceptive Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Contraceptive Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Contraceptive Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Contraceptive Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Contraceptive Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Contraceptive Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Contraceptive Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Contraceptive Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Contraceptive Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Contraceptive Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Merck Company Details
    Table 65. Merck Business Overview
    Table 66. Merck Contraceptive Drugs Product
    Table 67. Merck Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 68. Merck Recent Developments
    Table 69. Pfizer Company Details
    Table 70. Pfizer Business Overview
    Table 71. Pfizer Contraceptive Drugs Product
    Table 72. Pfizer Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 73. Pfizer Recent Developments
    Table 74. Teva Pharmaceutical Company Details
    Table 75. Teva Pharmaceutical Business Overview
    Table 76. Teva Pharmaceutical Contraceptive Drugs Product
    Table 77. Teva Pharmaceutical Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 78. Teva Pharmaceutical Recent Developments
    Table 79. Bayer Company Details
    Table 80. Bayer Business Overview
    Table 81. Bayer Contraceptive Drugs Product
    Table 82. Bayer Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 83. Bayer Recent Developments
    Table 84. Allergan Company Details
    Table 85. Allergan Business Overview
    Table 86. Allergan Contraceptive Drugs Product
    Table 87. Allergan Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 88. Allergan Recent Developments
    Table 89. Janssen Company Details
    Table 90. Janssen Business Overview
    Table 91. Janssen Contraceptive Drugs Product
    Table 92. Janssen Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 93. Janssen Recent Developments
    Table 94. Mankind Pharma Company Details
    Table 95. Mankind Pharma Business Overview
    Table 96. Mankind Pharma Contraceptive Drugs Product
    Table 97. Mankind Pharma Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 98. Mankind Pharma Recent Developments
    Table 99. Piramal Enterprises Company Details
    Table 100. Piramal Enterprises Business Overview
    Table 101. Piramal Enterprises Contraceptive Drugs Product
    Table 102. Piramal Enterprises Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 103. Piramal Enterprises Recent Developments
    Table 104. Reckitt Benckiser Company Details
    Table 105. Reckitt Benckiser Business Overview
    Table 106. Reckitt Benckiser Contraceptive Drugs Product
    Table 107. Reckitt Benckiser Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 108. Reckitt Benckiser Recent Developments
    Table 109. Church & Dwight Company Details
    Table 110. Church & Dwight Business Overview
    Table 111. Church & Dwight Contraceptive Drugs Product
    Table 112. Church & Dwight Revenue in Contraceptive Drugs Business (2019-2024) & (US$ Million)
    Table 113. Church & Dwight Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Contraceptive Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Contraceptive Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Injectable Features
    Figure 5. Others Features
    Figure 6. Global Contraceptive Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Contraceptive Drugs Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Contraceptive Drugs Report Years Considered
    Figure 12. Global Contraceptive Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Contraceptive Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Contraceptive Drugs Market Share by Region: 2023 VS 2030
    Figure 15. Global Contraceptive Drugs Market Share by Players in 2023
    Figure 16. Global Top Contraceptive Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Drugs as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Contraceptive Drugs Revenue in 2023
    Figure 18. North America Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Contraceptive Drugs Market Share by Type (2019-2030)
    Figure 20. North America Contraceptive Drugs Market Share by Application (2019-2030)
    Figure 21. North America Contraceptive Drugs Market Share by Country (2019-2030)
    Figure 22. United States Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Contraceptive Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Contraceptive Drugs Market Share by Type (2019-2030)
    Figure 26. Europe Contraceptive Drugs Market Share by Application (2019-2030)
    Figure 27. Europe Contraceptive Drugs Market Share by Country (2019-2030)
    Figure 28. Germany Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Contraceptive Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Contraceptive Drugs Market Share by Type (2019-2030)
    Figure 36. China Contraceptive Drugs Market Share by Application (2019-2030)
    Figure 37. Asia Contraceptive Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Contraceptive Drugs Market Share by Type (2019-2030)
    Figure 39. Asia Contraceptive Drugs Market Share by Application (2019-2030)
    Figure 40. Asia Contraceptive Drugs Market Share by Region (2019-2030)
    Figure 41. Japan Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Contraceptive Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Contraceptive Drugs Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Contraceptive Drugs Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Contraceptive Drugs Market Share by Country (2019-2030)
    Figure 51. Brazil Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Contraceptive Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Merck Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 58. Pfizer Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 59. Teva Pharmaceutical Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 60. Bayer Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 61. Allergan Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 62. Janssen Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 63. Mankind Pharma Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 64. Piramal Enterprises Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 65. Reckitt Benckiser Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 66. Church & Dwight Revenue Growth Rate in Contraceptive Drugs Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed